We are live on ! Find out more
Mariner

Mariner Portfolio holdings

AUM $85.7B
1-Year Est. Return 24.21%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$25B
AUM Growth
+$667M
Cap. Flow
+$2.22B
Cap. Flow %
8.89%
Top 10 Hldgs %
21.08%
Holding
2,467
New
1,096
Increased
959
Reduced
373
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 12.03%
2 Financials 8.33%
3 Healthcare 8.11%
4 Consumer Discretionary 5.72%
5 Consumer Staples 4.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRX icon
2401
TRX Gold Corp
TRX
$255M
$10K ﹤0.01%
+24,680
New +$10.8K
TUYA
2402
Tuya Inc
TUYA
$1.01B
$10K ﹤0.01%
+10,843
New +$17.5K
LOGC
2403
DELISTED
ContextLogic
LOGC
$10K ﹤0.01%
+447
New +$18.5K
OGI
2404
Organigram Holdings
OGI
$132M
$9K ﹤0.01%
+2,722
New +$11.4K
FFAI
2405
Faraday Future Intelligent Electric
FFAI
$15.8M
0
UFAB
2406
DELISTED
Unique Fabricating, Inc.
UFAB
$9K ﹤0.01%
+16,562
New +$15.5K
CGEN icon
2407
Compugen
CGEN
$216M
$8K ﹤0.01%
+11,987
New +$16.9K
UXIN
2408
Uxin Ltd
UXIN
$330M
$8K ﹤0.01%
+138
New +$9.35K
ASXC
2409
DELISTED
Asensus Surgical, Inc.
ASXC
$8K ﹤0.01%
+16,920
New +$8.82K
MMAT
2410
DELISTED
Meta Materials Inc. Common Stock
MMAT
$8K ﹤0.01%
+120
New +$10.5K
LPCN icon
2411
Lipocine
LPCN
$17.1M
$6K ﹤0.01%
+804
New +$8.98K
NBSE
2412
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$6K ﹤0.01%
+775
New +$12.8K
WTER
2413
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$6K ﹤0.01%
+1,133
New +$8.04K
VYNT
2414
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$6K ﹤0.01%
+2,055
New +$7.76K
CARM
2415
DELISTED
Carisma Therapeutics
CARM
$5K ﹤0.01%
+636
New +$8.66K
ACGN
2416
DELISTED
Aceragen Inc
ACGN
$5K ﹤0.01%
+725
New +$5.47K
IBIO icon
2417
iBio
IBIO
$71M
$4K ﹤0.01%
+45
New +$6.19K
SPCB icon
2418
SuperCom
SPCB
$67.3M
$4K ﹤0.01%
+70
New +$4.61K
HEXO
2419
DELISTED
HEXO Corp. Common Shares
HEXO
$4K ﹤0.01%
+1,498
New +$4.26K
VYNE icon
2420
VYNE Therapeutics
VYNE
$340K
$3K ﹤0.01%
+776
New +$4.97K
MARK
2421
DELISTED
Remark Holdings, Inc.
MARK
$3K ﹤0.01%
+1,000
New +$4.04K
VTGN icon
2422
VistaGen Therapeutics
VTGN
$9.29M
$2K ﹤0.01%
+428
New +$4.24K
HURA
2423
TuHURA Biosciences
HURA
$134M
$2K ﹤0.01%
+10
New +$3.2K
PHGE.WS
2424
DELISTED
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
$1K ﹤0.01%
+31,150
New +$1.28K
BBEU icon
2425
JPMorgan BetaBuilders Europe ETF
BBEU
$9.13B
-14,605
Closed -$673K

Similar funds

Mariner's Q3 2022 Portfolio in Review

As of Q3 2022, Mariner held 2,467 positions worth $25B, up 2.7% from $24.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Mariner deployed $2.22B of net new capital in Q3 2022, opening 1,096 new positions and adding to 959 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 58 shares worth $23.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 1000 ETF, an estimated $27.1M trimmed.

  • Mariner's largest Q3 2022 buy was Berkshire Hathaway Class A: 58 shares worth $23.6M.
  • Mariner added most to Vanguard FTSE Emerging Markets ETF in Q3 2022, an estimated $64.4M increase.
  • Mariner's biggest Q3 2022 reduction was iShares Russell 1000 ETF, cutting an estimated $27.1M.
  • Mariner fully exited Kohl's in Q3 2022, selling an estimated $3.89M.
  • Mariner's ten largest holdings make up 21% of its $25B portfolio in Q3 2022.
  • Mariner opened 1,096 new positions and closed 24 in Q3 2022.
  • Mariner's portfolio value rose 2.7% quarter-over-quarter to $25B.

Based on Mariner's 13F filing for Q3 2022, filed 10 Nov 2022.